AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

19.35
Delayed Data
As of Apr 20
 -0.50 / -2.52%
Today’s Change
11.93
Today|||52-Week Range
24.85
+46.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues124.4M418.3M532.1M609.9M
 
 
 
 
 
Cost of Goods Sold13.3M20.5M29.5M45.6M
 
 
 
 
 
Depreciation And Amortization7.0M69.1M99.9M153.3M
 
 
 
 
 
 
Operating ExpensesGross Income104.1M328.7M402.7M411.1M
 
 
 
 
 
General Expenses97.1M197.9M277.7M366.9M
 
 
 
 
 
Research And Development24.2M42.9M66.1M75.0M
 
 
 
 
 
Total Operating Expenses117.4M287.4M407.2M565.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income7.0M130.9M124.9M44.1M
 
 
 
 
 
Extraordinary Credit681.0K0.000.0047.7M
 
 
 
Extraordinary Charge-11.5M-32.5M-46.1M-396.0M
 
 
 
 
 
Interest Expense On Debt14.7M60.0M73.2M68.4M
 
 
 
 
 
Other Expenses217.0K1.5M189.0K-335.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.3M39.8M9.1M-370.1M
 
 
 
 
 
Income Taxes-153.2M-7.1M-11.5M-170.9M
 
 
 
 
 
Net Income135.8M32.8M-2.5M-199.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.4M31.5M34.3M34.9M
 
 
 
 
 
Shares To Calculate EPS Diluted25.2M35.3M34.3M34.9M
 
 
 
 
 
 
Earnings Per ShareEPS$5.45$0.93-$0.07-$5.71
 
 
 
 
 
EPS Diluted$5.38$0.93-$0.07-$5.71